Advanced search
Publication Cover
mAbs Volume 8, 2016 - Issue 3
Submit an article Journal homepage
7,650
Views
60
CrossRef citations to date
0
Altmetric
Reports

Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity

Anette KarleNovartis Pharma AG, Basel, Switzerland
,
Sebastian SpindeldreherNovartis Pharma AG, Basel, Switzerland
&
Frank KolbingerNovartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
Pages 536-550 | Received 10 Jul 2015, Accepted 22 Dec 2015, Published online: 04 Mar 2016

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.